Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men

The paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improve...

Full description

Bibliographic Details
Format: Article
Language:English
Published: Endocrinology Research Centre 2013-03-01
Series:Ожирение и метаболизм
Subjects:
Online Access:https://endojournals.ru/index.php/omet/article/view/5071
id doaj-ee23bcd862fd4dbbb5882ee580f4a5c5
record_format Article
spelling doaj-ee23bcd862fd4dbbb5882ee580f4a5c52021-10-02T16:09:33ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242013-03-01101434610.14341/2071-8713-50715029Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in menThe paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improved sexual function without causing severe side effects. A number of patients on therapy observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation.https://endojournals.ru/index.php/omet/article/view/5071тестостерона ундеканоатожирениеметаболический синдроммужчиныгипогонадизмандрогенная терапия
collection DOAJ
language English
format Article
sources DOAJ
title Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
spellingShingle Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Ожирение и метаболизм
тестостерона ундеканоат
ожирение
метаболический синдром
мужчины
гипогонадизм
андрогенная терапия
title_short Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
title_full Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
title_fullStr Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
title_full_unstemmed Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
title_sort experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
publisher Endocrinology Research Centre
series Ожирение и метаболизм
issn 2071-8713
2306-5524
publishDate 2013-03-01
description The paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improved sexual function without causing severe side effects. A number of patients on therapy observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation.
topic тестостерона ундеканоат
ожирение
метаболический синдром
мужчины
гипогонадизм
андрогенная терапия
url https://endojournals.ru/index.php/omet/article/view/5071
_version_ 1716852768359055360